ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,34
1,34%
Dow Jones
39 134,76
0,77%
DAX
18 254,18
1,03%
Brent Oil
85,005
0,37%
Bitcoin
65 095,32
0,20%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sensei Biotherapeutics Inc (SNSE)

  7. Sensei Biotherapeutics Inc (SNSE) Actualités

SNSE Sensei Biotherapeutics Inc

0,607
0,015 (2,53%)
Après les heures de négociation
Dernière mise à jour : 22:02:35
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Sensei Biotherapeutics Inc SNSE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,015 2,53% 0,607 22:02:35
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,604 0,5825 0,639 0,607 0,592
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/6/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:45EDGAR2Form 8-K - Current report
03/6/202413:31EDGAR2Form 8-K - Current report
23/5/202423:10EDGAR2Form 8-K - Current report
09/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:37EDGAR2Form 8-K - Current report
05/3/202422:44EDGAR2Form 8-K - Current report
28/2/202413:31EDGAR2Form 8-K - Current report
17/2/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:31EDGAR2Form 8-K - Current report
04/1/202414:14EDGAR2Form 8-K - Current report
07/11/202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:35EDGAR2Form 8-K - Current report
07/11/202313:30GLOBESensei Biotherapeutics Reports Third Quarter 2023 Financial..
06/11/202312:07EDGAR2Form 8-K - Current report
03/11/202321:11EDGAR2Form 8-K - Current report
03/11/202321:05GLOBESensei Biotherapeutics Reports Favorable Clinical Data for..
02/11/202321:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202321:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202312:30GLOBESensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as..
25/10/202315:05GLOBESensei Biotherapeutics to Present Initial Clinical Data from..
23/10/202313:30GLOBESensei Biotherapeutics Presents Trial-in-Progress Poster for..
20/10/202323:01EDGAR2Form 8-K - Current report
27/9/202313:30GLOBESensei Biotherapeutics Announces Initiation of Combination..
21/9/202313:30GLOBESensei Biotherapeutics Presents New Preclinical Data..
13/9/202314:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202313:30GLOBESensei Biotherapeutics to Present New Preclinical Data..
11/9/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202323:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202323:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202313:30GLOBESensei Biotherapeutics to Participate in Upcoming Investor..
17/8/202323:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:45EDGAR2Form 8-K - Current report
03/8/202313:30GLOBESensei Biotherapeutics Reports Second Quarter 2023 Financial..
02/8/202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202313:30GLOBESensei Biotherapeutics to Participate in Canaccord Genuity’s..
12/7/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202322:31EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
SNSE
Sensei Biotherapeutics
BIT
F18805
Vontobel Financial Produ...
NYSE
MTB-H
M&T Bank
BIT
F19001
Vontobel Financial Produ...
BIT
P1HXC4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés